A Multicenter, Phase 2, Randomized, Open-label, Active-controlled, Parallel Group Clinical Trial to Investigate the Safety, Tolerability, and Efficacy of Different Dose Levels of Once-weekly Lonapegsomatropin Compared to Daily Somatropin in Prepubertal Individuals With Turner Syndrome

Condition:   Turner Syndrome Interventions:   Biological: Lonapegsomatropin;   Device: Somatropin Sponsor:   Ascendis Pharma Endocrinology Division A/S Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials